ARTICLES - Tyrosine Kinase Inhibitors 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido(d)pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1999 |
|---|---|
| Erschienen: |
1999 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of medicinal chemistry - 42(1999), 10, Seite 1803-1815 |
| Beteiligte Personen: |
Smaill, Jeff B. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
13 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1554450071 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1554450071 | ||
| 003 | DE-627 | ||
| 005 | 20230508061454.0 | ||
| 007 | tu | ||
| 008 | 990609s1999 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a SW990609 |
| 035 | |a (DE-627)OLC1554450071 | ||
| 035 | |a (DE-599)GBVOLC1554450071 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 540 |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.42 |2 bkl | ||
| 100 | 1 | |a Smaill, Jeff B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ARTICLES - Tyrosine Kinase Inhibitors 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido(d)pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor |
| 264 | 1 | |c 1999 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Palmer, Brian D. |4 oth | |
| 700 | 1 | |a Rewcastle, Gordon W. |4 oth | |
| 700 | 1 | |a Denny, William A. |4 oth | |
| 700 | 1 | |a McNamara, Dennis J. |4 oth | |
| 700 | 1 | |a Dobrusin, Ellen M. |4 oth | |
| 700 | 1 | |a Bridges, Alexander J. |4 oth | |
| 700 | 1 | |a Zhou, Hairong |4 oth | |
| 700 | 1 | |a Hollis Showalter, H.D. |4 oth | |
| 700 | 1 | |a Thomas Winters, R. |4 oth | |
| 700 | 1 | |a Leopold, Wilbur R. |4 oth | |
| 700 | 1 | |a Fry, David W. |4 oth | |
| 700 | 1 | |a Nelson, James M. |4 oth | |
| 700 | 1 | |a Slintak, Veronika |4 oth | |
| 700 | 1 | |a Elliot, William L. |4 oth | |
| 700 | 1 | |a Roberts, Billy J. |4 oth | |
| 700 | 1 | |a Vincent, Patrick W. |4 oth | |
| 700 | 1 | |a Patmore, Sandra J. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Easton, Pa. : American Chemical Society, 1963 |g 42(1999), 10, Seite 1803-1815 |w (DE-627)129545201 |w (DE-600)218133-2 |w (DE-576)014995336 |x 0022-2623 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:1999 |g number:10 |g pages:1803-1815 |g extent:13 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_48 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a GBV_ILN_168 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a GBV_ILN_2221 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4028 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4082 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4309 | ||
| 912 | |a GBV_ILN_4314 | ||
| 912 | |a GBV_ILN_4315 | ||
| 936 | b | k | |a 44.42 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 42 |j 1999 |e 10 |h 1803-1815 |g 13 | ||